Trends in Human Papillomavirus Testing Among Patients With Oropharyngeal Cancer.

ABSTRACT:

Importance

Due to the prognostic value of human papillomavirus (HPV) status, HPV testing for oropharyngeal squamous cell carcinoma (OPSCC) has been recommended since 2012. However, recent HPV testing rates and associated sociodemographic and clinical factors are unknown.

Objective

To examine HPV testing rates stratified by sociodemographic and clinical factors and factors associated with increased likelihood of not receiving HPV testing from 2013 to 2021.

Design, setting, and participants

In this hospital-based cross-sectional study, the National Cancer Database (NCDB) was queried in 2024 for any patient diagnosed with OPSCC from 2013 to 2021, creating a retrospective cohort of 135 756 individuals. Two subsets were formed based on year of diagnosis: 2013-2017 and 2018

SUBMITTER: Carlson KM 

PROVIDER: S-EPMC12308448 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature